For decades, nitric oxide (NO) was known as a fleeting gas that helped vessels relax. Today, it stands as one of the most important molecular bridges between cardiovascular and sexual health, an axis that defines quality of life and longevity in men. What was once dismissed as an obscure signaling molecule has become central to understanding endothelial biology, metabolic regulation and the very mechanism of erection itself.

This is not the NO of gym posters and pre-workout drinks. The newer literature, spanning cardiovascular research, urology and nutraceutical science, makes it clear: supporting NO bioavailability should be as foundational to men’s health as managing every other aspect of cardiometabolic health.

The Physiology: A Gas that Behaves Like a Hormone

NO is a gaseous free radical, yet it behaves with the precision of a hormone. Produced in endothelial cells, neurons and immune tissues, it diffuses effortlessly across membranes to regulate vascular tone, mitochondrial efficiency and neurotransmission. Though “free radical” often implies damage, NO is the exception that defines the rule, a signaling radical generated in tightly controlled bursts. At physiologic levels, it activates soluble guanylyl cyclase to drive vasodilation and oxygen delivery; at excessive levels, or under oxidative stress, it can couple with superoxide to form peroxynitrite, a reminder that its benefits depend entirely on redox balance. In health, NO represents one of the body’s most elegant paradoxes: a radical messenger that sustains life by precisely controlling how blood, oxygen and energy flow.

When released from the endothelium, NO activates soluble guanylyl cyclase (sGC) in nearby smooth-muscle cells. This conversion of GTP to cyclic GMP (cGMP) leads to protein kinase G (PKG) activation, triggering smooth-muscle relaxation, vasodilation and inhibition of platelet aggregation. The result is improved blood flow, better oxygen delivery and reduced vascular resistance, all accomplished in a matter of seconds.

But NO’s reach extends far beyond circulation. It modulates mitochondrial respiration by reversibly binding to cytochrome c oxidase, fine-tuning oxygen consumption and reducing reactive oxygen species (ROS) generation. It also influences immune function and neuronal signaling, creating an intricate web of cross-system regulation. This vast interconnectedness positions NO as a fundamental part of any cardiometabolic protocol.

Overcoming the “Nitrate Fear”

One question that might come up from patients involves the positioning of nitrates as being harmful. Many hear “nitrate” and think “processed meat, nitrites, carcinogens.” That concern arises because nitrates and nitrites in processed meats, under high-heat cooking with a poor antioxidant environment, can form nitrosamines, which are risk-laden. But this is not the same context as vegetable-derived nitrates or standardized supplements. Vegetable nitrates come with antioxidants, betalains, polyphenols, context that inhibits harmful nitrosamine formation and enhances NO generation. Regulatory agencies (for example in Europe) have long set acceptable daily intakes (ADI) for nitrates (~3.7 mg/kg body weight/day) and nitrites (~0.07 mg/kg/day) in food additives, meaning safe baseline exposure has been established. However, when it comes to applying nitrates in clinical practice, the proper context (vegetables or standardized nitrate intake) and with appropriate antioxidant formulation, nitrate conversion to NO is a therapeutic strength, not something to be concerned about.

Two Pathways, One Goal: Maintaining Bioavailability

The body generates NO through two complementary routes, enzymatic synthesis and dietary nitrate reduction. Understanding both is crucial for clinicians guiding patients toward sustainable NO support.

The L-Arginine/eNOS Pathway

This is the classic, oxygen-dependent mechanism. Here, L-arginine is converted to NO and L-citrulline by NO synthase (NOS) enzymes, primarily endothelial NOS (eNOS). The process depends on cofactors like tetrahydrobiopterin (BH₄), FAD and FMN, and is sensitive to oxidative stress. When oxidative conditions deplete BH₄, eNOS becomes uncoupled, producing superoxide instead of NO. This shift accelerates endothelial dysfunction and vascular aging, a process familiar to clinicians managing hypertension, insulin resistance or chronic inflammation.

The Nitrate-Nitrite NO Pathway

The second mechanism operates independently of oxygen, making it particularly relevant under hypoxic conditions, during exercise, sexual arousal or ischemia. Dietary nitrate (NO₃–) from foods such as beets, spinach and arugula is absorbed in the gut, circulates systemically, and is then actively secreted into saliva.

There, the oral microbiome, notably species like Neisseria and Actinomyces, reduces nitrate to nitrite (NO₂–). When swallowed, this nitrite can be further reduced to NO in the acidic stomach or by enzymes such as xanthine oxidoreductase and deoxyhemoglobin.

This enterosalivary cycle operates as a backup system for NO production, one that becomes increasingly vital as endothelial function declines with age. For older men or those with vascular disease, this alternative pathway can restore perfusion and tissue oxygenation when the enzymatic route falters.

NO’s Reach: Cardiovascular, Metabolic and Sexual Systems

Within the vasculature, NO maintains endothelial homeostasis by balancing vasodilation with anti-inflammatory, antithrombotic and antioxidant effects. It suppresses leukocyte adhesion, prevents platelet aggregation and dampens smooth-muscle proliferation, all fundamental in preventing atherosclerosis.

Cardiac tissue benefits similarly. NO regulates coronary flow and modulates calcium signaling, thereby limiting maladaptive hypertrophy and arrhythmogenic potential. Mitochondrial studies show that NO improves oxygen efficiency and may protect the myocardium during reperfusion injury.

In the skeletal muscle, NO’s influence on cytochrome c oxidase enhances oxygen economy, improving endurance and recovery. These same mechanisms underpin the performance and energy benefits often observed in physically active men using nitrate-rich supplements.

And then there’s its role in sexual function, the original clinical application that brought NO into mainstream medicine. Penile erection is a NO-mediated event, dependent on both neuronal and endothelial NO release. Upon sexual stimulation, neuronal NOS (nNOS) releases NO from cavernous nerves to initiate erection, while endothelial NOS sustains it by promoting continued blood flow into the corpora cavernosa. The resulting rise in cGMP leads to smooth-muscle relaxation and engorgement.

Phosphodiesterase-5 (PDE-5) inhibitors, such as sildenafil, act downstream by preventing cGMP degradation. However, these drugs are only as effective as the upstream availability of NO. Without adequate NO signaling, the pharmacologic amplification falls flat, making dietary and metabolic NO support a valuable adjunct in sexual-medicine protocols.

The Microbiome Connection

An emerging revelation in the last few years is the degree to which the oral microbiome determines NO bioavailability. Antimicrobial mouthwashes, particularly those containing chlorhexidine or cetylpyridinium chloride, can devastate nitrate-reducing bacteria within days. Studies show that routine use of such rinses elevates blood pressure by up to 10 mmHg by suppressing salivary nitrite formation.

Inversely, restoring or protecting these bacterial communities, through diet, probiotics or reduced use of antiseptic rinses, supports a healthy enterosalivary nitrate cycle. For men seeking natural cardiovascular and sexual optimization, maintaining this microbial partnership may be as important as the supplements themselves.

Measuring What Matters

Salivary NO test strips, which rely on a modified Griess reaction, provide a practical, low-cost proxy for nitrate reduction capacity. While they do not directly reflect plasma nitrite or endothelial function, they serve as a behavioral biomarker, encouraging adherence and providing trend data. Low readings often indicate either insufficient dietary nitrate or disrupted oral microbiota.

For clinical settings, more accurate assessments such as plasma nitrate/nitrite levels or flow-mediated dilation (FMD) remain gold standards. However, the accessibility of salivary testing makes it a useful motivational tool for patients engaged in lifestyle-based vascular programs.

Novel Natural Interventions

S7: Polyphenol-driven Endothelial Activation

Unlike nitrate donors, S7 (FutureCeuticals) is a low-dose botanical blend that boosts endogenous NO production by enhancing eNOS signaling and mitigating oxidative destruction of NO. Comprised of green coffee bean, green tea, turmeric, tart cherry, blueberry, broccoli and kale extracts, S7 has been shown in a 90-day, double-blind clinical trial to increase plasma NO metabolites by 230 percent while reducing total reactive oxygen species.

Mechanistically, polyphenols within S7 activate the PI3K–Akt pathway, leading to eNOS phosphorylation (Ser1177) and higher NO output. They also facilitate BH₄ recycling and quench superoxide radicals that would otherwise combine with NO to form peroxynitrite. The net result: improved endothelial responsiveness and greater NO bioavailability, independent of dietary nitrate intake.

Potassium Nitrate: Precision Substrate Delivery

As an inorganic nitrate salt, potassium nitrate (KNO₃) directly feeds the nitrate–nitrite–NO pathway while conferring the added benefit of potassium-mediated vasodilation. Clinical crossover studies demonstrate 4-5 mmHg reductions in systolic pressure within 24 hours of ingestion, paralleling results seen with nitrate-rich beet juice.

Because nitrate pharmacokinetics are well characterized, clinicians can titrate dose with precision, typically 300-800 mg nitrate/day, yielding peak plasma nitrate at 1.5-2 hours and nitrite at 3-4 hours post-dose. Caution is warranted in patients with renal insufficiency or those on potassium-sparing medications due to hyperkalemia risk.

Beet Extract: The Gold Standard of Natural Nitrate

Among natural sources, beetroot extract remains the most thoroughly studied. Standardized preparations reliably deliver 300-800 mg nitrate per serving. Meta-analyses up to 2024 confirm systolic reductions of 8-9 mmHg and consistent improvements in FMD. Beyond nitrate, beetroot provides betalains and polyphenols that protect NO from oxidative degradation.

Intriguingly, 2025 data from the University of Exeter revealed that older adults exhibit a stronger BP-lowering response than younger cohorts, correlating with an increase in oral nitrate-reducing bacteria. This suggests that dietary nitrate not only supplies substrate but may reshape the microbiome to sustain its own production loop.

Integrating NO Support Into Clinical Practice

From a practical standpoint, incorporating NO support into men’s health care follows a stepwise logic:

1. Evaluate baseline endothelial health: blood pressure, lipid profile, insulin sensitivity and oral hygiene habits.

2. Select a primary mechanism: S7 for oxidative endothelial dysfunction, beet extract or potassium nitrate for substrate limitation, or a combination for synergistic action.

3. Dose appropriately: Beet-derived nitrate at 300-800 mg/day, S7 once daily with meals.

4. Preserve the oral pathway: Advise patients to avoid routine antimicrobial mouthwashes and emphasize vegetable-based diets.

5. Monitor outcomes: Track blood pressure, exercise tolerance, and, when relevant, erectile function metrics or FMD improvement over 8-12 weeks.

Safety remains favorable across studies, provided dosing stays within WHO (World Health Organization)-defined acceptable daily intakes (3.7 mg/kg for nitrate, 0.07 mg/kg for nitrite). Clinicians should, however, avoid co-administration with organic nitrates or PDE-5 inhibitors within 24 hours and use caution in patients with renal impairment.

The Foundational Case for NO

Endothelial dysfunction is the common denominator linking hypertension, coronary disease, insulin resistance and erectile dysfunction. NO sits at the center of this convergence. By restoring NO bioavailability, through enzymatic activation, nitrate supplementation or microbiome preservation, clinicians address a unifying mechanism rather than isolated symptoms. Supporting NO isn’t about chasing marginal performance; it’s about re-establishing physiologic balance that underpins cardiac, metabolic and sexual vitality. For men over 40, it may be the single most effective “silent intervention” for sustaining vascular youth.

In short: what statins did for lipids, NO may soon do for endothelial health, an upstream, system-wide benefit accessible through both diet and supplementation.

As research continues to unfold, one point is clear: NO deserves a permanent place in the foundational toolkit of men’s medicine, right beside the multivitamin, probiotic and CoQ10.

References:

1 Lundberg JO, Weitzberg E. Biochem Biophys Res Commun. 2020;518(3):544-549.

2 Kapil V, et al. Hypertension. 2024;83(2):309-318.

3 Shannon OM, et al. J Am Heart Assoc. 2025;14:e033901.

4 Jones AM, et al. Free Radic Biol Med. 2024;215:140-156.

5 Bryan NS, Loscalzo J. Nitric Oxide: Biology and Pathobiology. 3rd ed. Academic Press; 2022.

6 Webb AJ, et al. Hypertension. 2008;51:784-790.

7 Rael LT, et al. Clin Exp Pharmacol Physiol. 2021;48(9):1260-1268.

8 Bryan NS, et al. Nutrients. 2023;15(1):90.

9 Ma L, et al. Nutrients. 2024;16(5):870.

10 Li H, Forstermann U. Eur Heart J. 2019;40(30):2534-2548.

11 Gur S, et al. J Sex Med. 2022;19(7):1115-1126.

12 Melkonian EA, et al. Nutrients. 2024;16(1):125.

13 Sessa WC. Circ Res. 2017;120:1747-1759.

14 Vanhatalo A, et al. Hypertens Res. 2025;48:203-212.

15 Wylie LJ, et al. Nutrients. 2023;15(7):1678.

16 Kleinbongard P, et al. Circ Res. 2021;128:1292-1303.

17 EFSA Panel on Contaminants. EFSA J. 2017;15(4):4786.

18 Govoni M, et al. Free Radic Biol Med. 2020;152:134-146.

Adam Killpartrick is a chiropractor and functional medicine practitioner, CNS and DACBN. He has worked in clinical practice as well as held various positions within the supplement space, most recently as chief science officer and senior leadership team executive of a leading professional brand. He has also lent his expertise to the development of patented innovations and has had his research papers published in Molecules and International Journal of Molecular Sciences among others and has authored various chapters in textbooks including Functional Foods: Principles and Technology. Dr. Killpartrick is finishing his PhD at the University of Vermont in the field of nutrition and food science with a focus on novel methods of nutrient delivery.